AlembicPharma Gains 1% On USFDA Nod For Teriflunomide Tablets That Treat Sclerosis

AlembicPharma Gains 1% On USFDA Nod For Teriflunomide Tablets That Treat Sclerosis

Monday, April 22, 2019
Alembic Pharma now has a total of 91 ANDA approvals (79 final approvals and 12 tentative approvals) from USFDA.

Alembic Pharmaceuticals shares gained more than a percent intraday on April 22 after the #US health regulator approved Teriflunomide tablets, which are available in 7 mg and 14 mg strength.

For more information on Stock Tips For Tomorrow Nifty Call Option

and quick free trial click here > 911 133 9000

Visit http://www.epicresearch.co

Connect with our social media sites
Next
« Prev Post
Previous
Next Post »